Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cobra To Bio-Manufacture for Debiopharm | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Cobra To Bio-Manufacture for Debiopharm

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cobra Biomanufacturing has entered into an agreement with Debiopharm S.A., a Swiss drug development company, for the manufacture of the biopharmaceutical protein huTNF-Alpha Kinoid. The agreement includes process development and supply of material for clinical trials. The new agreement replaces a prior manufacturing deal with Neovacs SA that has licensed the program to Debiopharm. David Thatcher, chief executive officer of Cobra, said, “We are pleased to continue with the process development aspect of the TNF-Alpha Kinoid project while forging a new relationship with Debiopharm. This agreement recognizes Cobra’s previous success in this project and our expertise in producing therapeutic protein vaccines.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics